Annual Clinical Contract Evaluations: Are You Ready?

By AHRMM

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $99.00

CEC Hours: 1

Order Webinar

 

Description:

The process of annual clinical contract evaluations can be time consuming and overwhelming, and supply chain has a unique opportunity to support the continuum of care as we expand our CQO efforts and strive to meet requirements. In this webinar, we discuss the clinical contract evaluation process, including government requirements, expectations, and improving contract performance with the use of key performance indicators.

Attendees will hear firsthand what the Dana-Farber Cancer Institute (DFCI) learned during their last Joint Commission inspection regarding the evaluation process and the effectiveness of their contracts. In addition, DFCI will share how their annual clinical contract evaluation process has matured through the improvement of existing contract management technology and the automation of the evaluation process.

 

Learning Objectives:
  • Characterize a clinical contract.
  • Explain the annual clinical contract evaluation requirements.
  • Define key performance indicators.

 

Presenters:
  • Sarah Buck — Supply Chain Business Analyst, Dana-Farber Cancer Institute
  • Susan Wills — Director Strategic Sourcing and Contracts, Dana-Farber Cancer Institute

 

Related Resources

Advisory
New Guidance on Humidity Levels in the Operating Room
Request for Proposals (RFP)
Please see a sample of a Reprocessing Single Use Devices (SUD), RFP below - you will find this short document and the Reprocessing Narrative
Magazine & Journal Articles
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Advisory
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<